A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.

M Lia Palomba,Paola Ghione,Anik R Patel,Myrna Nahas,Sara Beygi,Anthony J Hatswell,Steve Kanters,Eve H Limbrick-Oldfield,Sally W Wade,Markqayne D Ray,Jessica Owen,Sattva S Neelapu,John Gribben,John Radford,Sabela Bobillo

Expert review of anticancer therapy（2023）

引用 2|浏览32

暂无评分

摘要

This updated analysis, using a longer minimum follow-up than a previously published analysis, shows that the improved efficacy of axi-cel, relative to available therapies, in r/r FL is durable. .

查看译文

关键词

Follicular lymphoma,ZUMA-5,axicabtagene ciloleucel,comparative effectiveness,propensity score analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要